XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition Jan 18, 2024 8:30am EST
FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx Jan 11, 2024 4:05pm EST
XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors Jan 08, 2024 7:30am EST
